Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03554629
Other study ID # MDT17063FRS
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 1, 2018
Est. completion date September 15, 2020

Study information

Verified date December 2020
Source Medtronic - MITG
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study evaluates the performance of eight (8) cleared capnography carbon dioxide (CO2) sampling filterlines during patient simulated scripted activities when connected to a Medtronic (MDT) dual parameter monitor.


Description:

The eight (8) Capnography CO2 Sampling Filterlines (CCSF) have different designs for obtaining a gas sample for CO2 measurement and also for delivering supplemental oxygen (O2). In this study awake, healthy volunteers will evaluate the 8 CCSF (Capnography CO2 Sampling Filterline) to determine their performance variability in providing a representative exhaled CO2 sample for measurement on the Capnostream 35 dual parameter monitor during scripted activities of closed mouth/open mouth breathing during both high and low respiration rate with supplemental oxygen delivery at 5lpm.


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date September 15, 2020
Est. primary completion date August 31, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: 1. Non-hospitalized adults = 18 years old. 2. Willing and able to give informed consent. Exclusion Criteria: 1. Lack of an informed consent. 2. Subjects not able to accommodate the proper application of the cannula. 3. Subject not willing or able to comply fully with the study procedures. 4. Subjects with sensitivity to nasal cannula in both nares. 5. Subject with skin allergies to medical adhesives. 6. Subjects with runny nose the day of the study participation. 7. Subject, who in the opinion of the Principal Investigator, should not be enrolled.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Capnography CO2 cannula sampling Flexiterline (CCSF) designs with supplemental O2
Use of 8 post-market nasal CO2 cannula sampling filterlines; 4 nasal only sampling ports manufactured by Medtronic, Salter, Hudson/Teleflex and FlexiCare) and 4 post-market oral/nasal sampling ports manufactured by Medtronic, Salter, Dispo-Med and Westmed during scripted activity with supplemental O2.

Locations

Country Name City State
United States Clinimark LLC Louisville Colorado

Sponsors (1)

Lead Sponsor Collaborator
Medtronic - MITG

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Capnography Measured CO2 Waveform Data as a Function of CO2 Cannula Sampling Filterline (CCSF) Stratified by Activity Comparison of measured end-tidal CO2 (EtCO2), Rebreathing as measured by fractional inspiratory CO2 (FiCO2) as a function the activity for 8 different CCSF designs tested on 23 subjects with supplemental O2 at 5lmp for four activities.
Device data collected a 20Hz (20 data points/second) for the 3 hours of enrollment.
Participants lateral lying with head on a pillow with supplemental O2 during each nasal only or open mouth breathing at respiration rate of 6 and 24.
Three hours
Secondary Average Number of Alarms as a Function of Each Capnography CO2 Cannula Sampling Filterline (CCSF) Stratified by Activity With an Actual Respiration Rate of 24 Gas sample provided by CCSF to the Capnostream 35 for measurement of the partial pressure of CO2 as a function of time.
The Capnostream 35 Respiration rate algorithm counts the breaths per minute based upon the frequency of a CO2 validated breath waveform.
Three hours
Secondary Average Number of Alarms as a Function of Each Capnography CO2 Cannula Sampling Filterline (CCSF) Stratified by Activity With an Actual Respiration Rate of 6 Gas sample provided by CCSF to the Capnostream 35 for measurement of the partial pressure of CO2 as a function of time.
The Capnostream 35 Respiration rate algorithm counts the breaths per minute based upon the frequency of a CO2 validated breath waveform.
Three hours
See also
  Status Clinical Trial Phase
Completed NCT03279458 - Non-invasive Tidal Volume Monitoring Using the Linshom Respiratory Monitoring Device N/A
Completed NCT02889770 - Dead Space Monitoring With Volumetric Capnography in ARDS Patients N/A
Active, not recruiting NCT05696860 - Microstream® Capnography in Endobronchial Ultrasonography Applications Under Sedation N/A
Not yet recruiting NCT05817864 - Diagnostic Accuracy of Capnography in Nasogastric Tube Placement
Completed NCT04962581 - A Prospective Descriptive Study of the Individualized Capnography of Both Lungs During One-lung Ventilation With Double-lumen Tube
Not yet recruiting NCT03025490 - The Use of Capnography and Integrated Pulmonary Index in the Electrophysiology Laboratory N/A
Completed NCT04316988 - Ultrasonography Versus Capnography in Detecting Endotracheal Tube Placement During Intubation in a Tertiary Hospital.
Completed NCT03370081 - Effects of Capnometry Monitoring in Post Anesthesia Care Unit N/A
Recruiting NCT03768973 - Pulmonary Effects of Diabetes Mellitus
Recruiting NCT04839419 - Obesity-hypoventilation in Metabolic Syndrom Patients